The novel thiol bridging "staple motif RS-Au-SR" discovered at the Au-thiolate interface has tremendously advanced the structural understanding of monolayer protected Au clusters (AuMPCs). In this paper, multidentate dithiol ligands are introduced into the monolayer of the Au clusters. The impacts of dithiols on the Au-monothiolate interfacial bonding and related physical properties are explored. A correlation is established of the near-IR luminescence with Au-tiopronin monothiol interactions that are constrained by the dithiol molecule structures. Two types of monolayer reaction are studied: (1) monothiol tiopronin AuMPCs with dithiol molecule 2,3-dimercaptopropanesulfonate (DMPS) and (2) DMPS Au dithiol clusters (AuDTCs) with tiopronin monothiol ligands. Upon the addition of excess DMPS molecules into tiopronin MPC solution, tiopronin molecules are efficiently liberated from the original AuMPCs monitored by proton NMR. The process is accompanied by the decrease of near-infrared luminescence of the tiopronin AuMPCs. A slower enhancement of the 282 nm absorption band is observed, a signature of DMPS Au4DTCs characterized by mass spectrometry. The analysis of the reaction kinetics reveals a two-step mechanism: a facile ligand replacement followed by a sluggish core etching process. The reverse approach, tiopronin molecules reacting with DMPS DTCs, results in the addition of tiopronin into DMPS monolayer instead of ligand exchange. Near-IR luminescence intensifies with the monolayer addition of tiopronin.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/la1045628 | DOI Listing |
Urolithiasis is a multifactorial condition where stone composition is critical in guiding treatment and prevention strategies. Advanced diagnostic techniques, such as infrared spectroscopy, provide precise stone analysis, enabling clinicians to tailor interventions based on specific stone types and associated metabolic abnormalities. Calcium oxalate monohydrate stones often require invasive approaches like percutaneous nephrolithotomy, while uric acid responds well to dissolution therapy.
View Article and Find Full Text PDFCurr Mol Med
January 2025
Department of Radiation Science, Hirosaki University Graduate School of Health Sciences, 66-1 Hon-cho, Hirosaki, Aomori 036-8564, Japan.
Background: The anticancer activity and radiosensitizing effect of Auranofin, an an-tirheumatic and an approved gold metallic drug, have been investigated from multiple perspectives. In this study, the action of the new gold complex compound TPN-Au(I)-MM4 was compared with that of auranofin.
Methods: The inhibitory effect of 10 μM and 50 μM concentrations on cell proliferation was investigated using the human colon cancer cell lines HCT116 and SW480.
RSC Adv
October 2024
School of Pharmacy, Newcastle University Newcastle Upon Tyne UK
Intern Med
September 2024
the University of Tokyo School of Medicine, Division of Nephrology and Endocrinology, Japan.
Tiopronin is a key drug used to treat cystinuria. A 41-year-old Japanese woman with cystinuria presented with eyelid edema and weight gain after the administration of tiopronin. Her serum albumin was 1.
View Article and Find Full Text PDFLangmuir
June 2024
Department of Biochemistry, Federal University of São Paulo, São Paulo 04044-020, Brazil.
Gold nanoparticles (AuNPs) hold promise in biomedicine, but challenges like aggregation, protein corona formation, and insufficient biocompatibility must be thoroughly addressed before advancing their clinical applications. Designing AuNPs with specific protein corona compositions is challenging, and strategies for corona elimination, such as coating with polyethylene glycol (PEG), have limitations. In this study, we introduce a commercially available zwitterionic derivative of glutathione, glutathione monoethyl ester (GSH), for the surface coating of colloidal AuNPs.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!